PRTC
Price
$16.70
Change
+$0.70 (+4.38%)
Updated
Nov 28 closing price
Capitalization
401.91M
2 days until earnings call
Intraday BUY SELL Signals
RLMD
Price
$4.51
Change
+$0.32 (+7.64%)
Updated
Nov 28 closing price
Capitalization
330.73M
113 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRTC vs RLMD

Header iconPRTC vs RLMD Comparison
Open Charts PRTC vs RLMDBanner chart's image
PureTech Health
Price$16.70
Change+$0.70 (+4.38%)
Volume$3.44K
Capitalization401.91M
Relmada Therapeutics
Price$4.51
Change+$0.32 (+7.64%)
Volume$341.23K
Capitalization330.73M
PRTC vs RLMD Comparison Chart in %
PRTC
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PRTC vs. RLMD commentary
Dec 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTC is a StrongBuy and RLMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 01, 2025
Stock price -- (PRTC: $16.70 vs. RLMD: $4.51)
Brand notoriety: PRTC and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTC: 103% vs. RLMD: 31%
Market capitalization -- PRTC: $401.91M vs. RLMD: $330.73M
PRTC [@Biotechnology] is valued at $401.91M. RLMD’s [@Biotechnology] market capitalization is $330.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTC’s FA Score shows that 1 FA rating(s) are green whileRLMD’s FA Score has 0 green FA rating(s).

  • PRTC’s FA Score: 1 green, 4 red.
  • RLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, PRTC is a better buy in the long-term than RLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRTC’s TA Score shows that 5 TA indicator(s) are bullish while RLMD’s TA Score has 4 bullish TA indicator(s).

  • PRTC’s TA Score: 5 bullish, 4 bearish.
  • RLMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRTC is a better buy in the short-term than RLMD.

Price Growth

PRTC (@Biotechnology) experienced а +4.83% price change this week, while RLMD (@Biotechnology) price change was +5.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

PRTC is expected to report earnings on Dec 03, 2025.

RLMD is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($402M) has a higher market cap than RLMD($331M). RLMD YTD gains are higher at: 767.308 vs. PRTC (-9.534). PRTC has higher annual earnings (EBITDA): 37.8M vs. RLMD (-70.52M). PRTC has more cash in the bank: 322M vs. RLMD (20.6M). RLMD has less debt than PRTC: RLMD (256K) vs PRTC (20.9M). PRTC has higher revenues than RLMD: PRTC (6.17M) vs RLMD (0).
PRTCRLMDPRTC / RLMD
Capitalization402M331M121%
EBITDA37.8M-70.52M-54%
Gain YTD-9.534767.308-1%
P/E Ratio9.82N/A-
Revenue6.17M0-
Total Cash322M20.6M1,563%
Total Debt20.9M256K8,164%
FUNDAMENTALS RATINGS
RLMD: Fundamental Ratings
RLMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRTCRLMD
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 13 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
PRTC
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EVSAX27.360.15
+0.55%
Allspring Disciplined US Core A
LKEQX40.980.15
+0.37%
LKCM Equity
CSIEX82.140.20
+0.24%
Calvert Equity A
IJPIX13.130.03
+0.23%
VY® JPMorgan Emerging Markets Equity S
SVPIX114.230.07
+0.06%
ProFunds Small Cap Value Inv

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and IRON have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and IRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
+4.38%
IRON - PRTC
32%
Poorly correlated
-0.42%
RLMD - PRTC
31%
Poorly correlated
+7.64%
ZLAB - PRTC
30%
Poorly correlated
+2.20%
PTCHF - PRTC
29%
Poorly correlated
N/A
AUTL - PRTC
28%
Poorly correlated
+2.92%
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+7.64%
SYRE - RLMD
36%
Loosely correlated
+0.84%
ENTO - RLMD
36%
Loosely correlated
+5.28%
PRTC - RLMD
31%
Poorly correlated
+4.38%
AVXL - RLMD
31%
Poorly correlated
-0.78%
PLUR - RLMD
30%
Poorly correlated
-1.01%
More